Detailed information for compound 1780303

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 402.467 | Formula: C19H22N4O4S
  • H donors: 2 H acceptors: 4 LogP: 0.75 Rotable bonds: 7
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C(Nc1ccc(cc1)S(=O)(=O)N1C2COCC1CC2)NCc1cccnc1
  • InChi: 1S/C19H22N4O4S/c24-19(21-11-14-2-1-9-20-10-14)22-15-3-7-18(8-4-15)28(25,26)23-16-5-6-17(23)13-27-12-16/h1-4,7-10,16-17H,5-6,11-13H2,(H2,21,22,24)
  • InChiKey: MBWVUAOCXJXCNQ-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens nicotinamide phosphoribosyltransferase Starlite/ChEMBL References
Homo sapiens cytochrome P450, family 2, subfamily C, polypeptide 9 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Echinococcus granulosus nicotinamide phosphoribosyltransferase Get druggable targets OG5_133520 All targets in OG5_133520
Schistosoma japonicum ko:K03462 nicotinamide phosphoribosyltransferase [EC2.4.2.12], putative Get druggable targets OG5_133520 All targets in OG5_133520
Schistosoma japonicum ko:K03462 nicotinamide phosphoribosyltransferase [EC2.4.2.12], putative Get druggable targets OG5_133520 All targets in OG5_133520
Echinococcus multilocularis nicotinamide phosphoribosyltransferase Get druggable targets OG5_133520 All targets in OG5_133520
Loa Loa (eye worm) cytochrome P450 family protein Get druggable targets OG5_126582 All targets in OG5_126582
Loa Loa (eye worm) pre-B cell enhancing factor Get druggable targets OG5_133520 All targets in OG5_133520
Brugia malayi Pre-B cell enhancing factor precursor Get druggable targets OG5_133520 All targets in OG5_133520
Schistosoma mansoni nicotinate phosphoribosyltransferase related pre-B cell enhancing factor Get druggable targets OG5_133520 All targets in OG5_133520
Brugia malayi Cytochrome P450 family protein Get druggable targets OG5_126582 All targets in OG5_126582

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Mycobacterium tuberculosis Probable cytochrome P450 136 Cyp136 cytochrome P450, family 2, subfamily C, polypeptide 9 490 aa 441 aa 21.8 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Loa Loa (eye worm) hypothetical protein 0.0933 0.552 0.4259
Trypanosoma brucei 6-phosphofructo-2-kinase 2 0.16 0.9823 0.9823
Echinococcus multilocularis 6 phosphofructo 2 kinase:fructose 2 0.1628 1 1
Trypanosoma cruzi 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.0695 0.398 0.398
Trypanosoma cruzi 6-phosphofructo-2-kinase 1 0.16 0.9823 0.9823
Onchocerca volvulus 0.1628 1 0.5
Brugia malayi Pre-B cell enhancing factor precursor 0.0418 0.2196 0.5
Mycobacterium ulcerans hypothetical protein 0.0961 0.5697 0.5
Giardia lamblia Hypothetical protein 0.0961 0.5697 0.5
Trichomonas vaginalis nicotinate phosphoribosyltransferase, putative 0.0078 0 0.5
Leishmania major 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.1628 1 1
Schistosoma mansoni 6-phosphofructokinase 0.1628 1 1
Giardia lamblia Hypothetical protein 0.0961 0.5697 0.5
Mycobacterium ulcerans fructose-2,6-bisphosphatase GpmB 0.0961 0.5697 0.5
Plasmodium falciparum nicotinate phosphoribosyltransferase, putative 0.0078 0 0.5
Trypanosoma cruzi 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.1628 1 1
Entamoeba histolytica phosphoglycerate mutase family protein, putative 0.0961 0.5697 1
Mycobacterium tuberculosis Nicotinic acid phosphoribosyltransferase PncB2 0.0078 0 0.5
Loa Loa (eye worm) hypothetical protein 0.16 0.9823 0.9773
Leishmania major 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-1-like protein 0.0695 0.398 0.398
Leishmania major 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.16 0.9823 0.9823
Loa Loa (eye worm) hypothetical protein 0.1628 1 1
Schistosoma mansoni nicotinate phosphoribosyltransferase related pre-B cell enhancing factor 0.0418 0.2196 0.2196
Trypanosoma cruzi 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.0695 0.398 0.398
Mycobacterium tuberculosis Nicotinic acid phosphoribosyltransferase PncB1 0.0078 0 0.5
Trypanosoma brucei 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.0695 0.398 0.398
Trypanosoma cruzi 6-phosphofructo-2-kinase 1 0.16 0.9823 0.9823
Trypanosoma cruzi 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.1628 1 1
Treponema pallidum nicotinate phosphoribosyltransferase 0.0078 0 0.5
Trypanosoma brucei 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.1628 1 1

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 10 nM Inhibition of NAMPT (unknown origin) assessed as NAM conversion to NMN preincubated for 15 mins prior to substrate addition measured after 30 mins by mass spectrophotometric analysis ChEMBL. 23668988
IC50 (functional) = 251 nM Antiproliferative activity against human A2780 cells after 72 hrs by sulforhodamine B assay ChEMBL. 23668988
IC50 (ADMET) = 1050 nM Inhibition of CYP2C9 in human liver microsomes after 30 mins ChEMBL. 23668988

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Homo sapiens ChEMBL23 23668988

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.